Physician profile
Bryan T Ho
NPI 1417960238
$1,471.94
in general payments reported to CMS, 2019-2025
17 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $105 · 2021: $158 · 2022: $247 · 2023: $449 · 2024: $169 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.16 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $369.78 | 2019-2025 | |
| Aerin Medical INC. | $356.29 | 2023-2025 | |
| Stryker Corporation | $262.55 | 2019-2022 | |
| Medtronic, INC. | $88.25 | 2024-2025 | Propel, Pteye Parathyroid Detection System |
| Genzyme Corporation | $78.37 | 2022-2025 | |
| Intersect Ent, INC. | $48.67 | 2020 | |
| Kaleo, INC. | $47.02 | 2022-2024 | Auvi-Q |
| Cochlear Americas | $39.02 | 2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Ars Pharmaceuticals Operations, INC. | $38.20 | 2025 | Neffy |
| Amgen INC. | $34.00 | 2025 | |
| Inspire Medical Systems, INC. | $24.35 | 2025 | Inspire |
| Karl Storz Endoscopy-America | $22.44 | 2025 | |
| Glaxosmithkline, LLC. | $20.21 | 2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $18.57 | 2025 | Tezspire |
| Pharming Healthcare, INC. | $12.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $11.99 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.